GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Change In Receivables

3B BlackBio Dx (BOM:532067) Change In Receivables : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Change In Receivables?

3B BlackBio Dx's change in receivables for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means 3B BlackBio Dx's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

3B BlackBio Dx's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-97.4 Mil. It means 3B BlackBio Dx's Accounts Receivable increased by ₹97.4 Mil from Mar. 2023 to Mar. 2024 .

3B BlackBio Dx's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹362.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. 3B BlackBio Dx's Days Sales Outstanding for the three months ended in Mar. 2024 was 143.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. 3B BlackBio Dx's liquidation value for the three months ended in Mar. 2024 was ₹710.5 Mil.


3B BlackBio Dx Change In Receivables Historical Data

The historical data trend for 3B BlackBio Dx's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Change In Receivables Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.06 -525.48 332.14 -17.73 -97.35

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

3B BlackBio Dx Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

3B BlackBio Dx's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=362.463/229.98*91
=143.82

2. In Ben Graham's calculation of liquidation value, 3B BlackBio Dx's accounts receivable are only considered to be worth 75% of book value:

3B BlackBio Dx's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=622.783-226.305+0.75 * 362.463+0.5 * 84.274
=710.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx Change In Receivables Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines